ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

ONS Adopts Scope Of Oncology Nursing Practice

November 23, 1984

DRCCA Staff Boom To 145, Still Growing, Still Looking for People

November 25, 1983

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

April 29, 1988

NCI advisors approve new grants programs. NCI funds consortium of cohorts. Funding opportunities listed.

August 1, 2003

Group Chairs Respond to Center Directors’ White Paper

April 1, 2011

Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’

December 11, 1992